BNP PARIBAS FINANCIAL MARKETS - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$3,000
-25.0%
10.0%0.00%
Q1 2022$4,000
-100.0%
1
-100.0%
0.00%
Q4 2021$142,913,000
+17899.1%
30,734
+15344.2%
0.00%
Q3 2021$794,000
-94.3%
199
-93.9%
0.00%
Q2 2021$13,901,000
+18.3%
3,248
+17.2%
0.00%
Q1 2021$11,753,000
-22.7%
2,772
-29.3%
0.00%
Q4 2020$15,206,000
-14.2%
3,919
-10.9%
0.00%
Q3 2020$17,724,000
+279.6%
4,398
+301.3%
0.00%
Q2 2020$4,669,000
-82.6%
1,096
-82.8%
0.00%
Q1 2020$26,762,000
+127.5%
6,372
+112.8%
0.00%
Q4 2019$11,766,000
-60.4%
2,994
-11.3%
0.00%
Q3 2019$29,700,000
+32.2%
3,375
+38.9%
0.00%
Q2 2019$22,468,000
-21.7%
2,429
-45.6%
0.00%
Q1 2019$28,697,000
+43380.3%
4,463
+63657.1%
0.00%
Q4 2018$66,000
-99.6%
7
-99.0%
0.00%
Q3 2018$14,695,000
-31.0%
7300.0%0.00%
Q2 2018$21,294,000
-80.5%
730
-80.1%
0.00%
Q1 2018$109,412,000
-6.1%
3,674
+1.5%
0.00%
Q4 2017$116,459,000
+92.9%
3,619
+108.5%
0.00%
Q3 2017$60,378,000
+9.5%
1,736
-6.3%
0.00%
Q2 2017$55,134,000
+2616.0%
1,852
+2623.5%
0.00%
Q1 2017$2,030,000
-85.1%
68
-91.3%
0.00%
Q4 2016$13,656,000
-41.3%
779
-20.3%
0.00%
Q3 2016$23,267,000
+169.8%
978
+81.4%
0.00%
Q2 2016$8,624,000
-89.2%
539
-81.8%
0.00%
Q4 2015$79,812,000
+11.1%
2,956
+14.3%
0.00%
Q3 2015$71,865,000
+205.1%
2,586
+169.1%
0.00%
Q2 2015$23,554,0009610.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders